An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
BACKGROUND: The artemisinin-based combination treatment (ACT) of dihydroartemisinin (DHA) and piperaquine (PQP) is a promising novel anti-malarial drug effective against multi-drug resistant falciparum malaria. The aim of this study was to show non-inferiority of DHA/PQP vs. artesunate-mefloquine (...
Hoofdauteurs: | Valecha, N, Phyo, A, Mayxay, M, Newton, P, Krudsood, S, Keomany, S, Khanthavong, M, Pongvongsa, T, Ruangveerayuth, R, Uthaisil, C, Ubben, D, Duparc, S, Bacchieri, A, Corsi, M, Rao, B, Bhattacharya, P, Dubhashi, N, Ghosh, S, Dev, V, Kumar, A, Pukrittayakamee, S, Pukittayakamee, S |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
Public Library of Science
2010
|
Gelijkaardige items
-
An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia
door: Valecha, N, et al.
Gepubliceerd in: (2010) -
A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern Laos.
door: Mayxay, M, et al.
Gepubliceerd in: (2010) -
An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).
door: Mayxay, M, et al.
Gepubliceerd in: (2006) -
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
door: Smithuis, F, et al.
Gepubliceerd in: (2006) -
Pyronaridine–Artesunate versus Mefloquine plus Artesunate for Malaria
door: Rueangweerayut, R, et al.
Gepubliceerd in: (2012)